Multicenter evaluation of signalment and comorbid conditions associated with aortic thrombotic disease in dogs

Randolph L. Winter Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL 36832.

Search for other papers by Randolph L. Winter in
Current site
Google Scholar
PubMed
Close
 DVM
and
Christine M. Budke Department of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843.

Search for other papers by Christine M. Budke in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

OBJECTIVE To assess signalment and concurrent disease processes in dogs with aortic thrombotic disease (ATD).

DESIGN Retrospective case-control study.

ANIMALS Dogs examined at North American veterinary teaching hospitals from 1985 through 2011 with medical records submitted to the Veterinary Medical Database.

PROCEDURES Medical records were reviewed to identify dogs with a diagnosis of ATD (case dogs). Five control dogs without a diagnosis of ATD were then identified for every case dog. Data were collected regarding dog age, sex, breed, body weight, and concurrent disease processes.

RESULTS ATD was diagnosed in 291 of the 984,973 (0.03%) dogs included in the database. The odds of a dog having ATD did not differ significantly by sex, age, or body weight. Compared with mixed-breed dogs, Shetland Sheepdogs had a significantly higher odds of ATD (OR, 2.59). Protein-losing nephropathy (64/291 [22%]) was the most commonly recorded concurrent disease in dogs with ATD.

CONCLUSIONS AND CLINICAL RELEVANCE Dogs with ATD did not differ significantly from dogs without ATD in most signalment variables. Contrary to previous reports, cardiac disease was not a common concurrent diagnosis in dogs with ATD.

Abstract

OBJECTIVE To assess signalment and concurrent disease processes in dogs with aortic thrombotic disease (ATD).

DESIGN Retrospective case-control study.

ANIMALS Dogs examined at North American veterinary teaching hospitals from 1985 through 2011 with medical records submitted to the Veterinary Medical Database.

PROCEDURES Medical records were reviewed to identify dogs with a diagnosis of ATD (case dogs). Five control dogs without a diagnosis of ATD were then identified for every case dog. Data were collected regarding dog age, sex, breed, body weight, and concurrent disease processes.

RESULTS ATD was diagnosed in 291 of the 984,973 (0.03%) dogs included in the database. The odds of a dog having ATD did not differ significantly by sex, age, or body weight. Compared with mixed-breed dogs, Shetland Sheepdogs had a significantly higher odds of ATD (OR, 2.59). Protein-losing nephropathy (64/291 [22%]) was the most commonly recorded concurrent disease in dogs with ATD.

CONCLUSIONS AND CLINICAL RELEVANCE Dogs with ATD did not differ significantly from dogs without ATD in most signalment variables. Contrary to previous reports, cardiac disease was not a common concurrent diagnosis in dogs with ATD.

Contributor Notes

Address correspondence to Dr. Winter (Rlw0041@auburn.edu).
  • 1. Smith SA, Tobias AH. Feline arterial thromboembolism: an update. Vet Clin North Am Small Anim Pract 2004; 34: 1245–1271.

  • 2. Smith SA, Tobias AH, Jacob KA, et al. Arterial thromboembolism in cats: acute crisis in 127 cases (1992–2001) and long-term management with low-dose aspirin in 24 cases. J Vet Intern Med 2003; 17: 73–83.

    • Search Google Scholar
    • Export Citation
  • 3. Welch KM, Rozanski EA, Freeman LM, et al. Prospective evaluation of tissue plasminogen activator in 11 cats with arterial thromboembolism. J Feline Med Surg 2010; 12: 122–128.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4. Bowles DB, Coleman MG, Harvey CJ. Cardiogenic arterial thromboembolism causing non-ambulatory tetraparesis in a cat. J Feline Med Surg 2010; 12: 144–150.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5. Reimer SB, Kittleson MD, Kyles AE. Use of rheolytic thrombectomy in the treatment of feline distal aortic thromboembolism. J Vet Intern Med 2006; 20: 290–296.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6. Van Winkle TJ, Hackner SG, Liu SM. Clinical and pathological features of aortic thromboembolism in 36 dogs. J Vet Emerg Crit Care 1993; 3: 13–21.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7. Boswood A, Lamb CR, White RN. Aortic and iliac thrombosis in six dogs. J Small Anim Pract 2000; 41: 109–114.

  • 8. Gonçalves R, Penderis J, Chang YP, et al. Clinical and neurological characteristics of aortic thromboembolism in dogs. J Small Anim Pract 2008; 49: 178–184.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9. Ramsey CC, Burney DP, Macintire DK, et al. Use of streptokinase in four dogs with thrombosis. J Am Vet Med Assoc 1996; 209: 780–785.

    • Search Google Scholar
    • Export Citation
  • 10. Clare AC, Kraje BJ. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog. J Am Vet Med Assoc 1998; 212: 539–543.

    • Search Google Scholar
    • Export Citation
  • 11. Winter RL, Sedacca CD, Adams A, et al. Aortic thrombosis in dogs: presentation, therapy, and outcome in 26 cases. J Vet Cardiol 2012; 14: 333–342.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12. Lake-Bakaar GA, Johnson EG, Griffiths LG. Aortic thrombosis in dogs: 31 cases (2000–2010). J Am Vet Med Assoc 2012; 241: 910–915.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13. Santamarina G, Espino L, Vila M, et al. Aortic thromboembolism and retroperitoneal hemorrhage associated with a pheochromcytoma in a dog. J Vet Intern Med 2003; 17: 917–922.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14. Borgeat K, Wright J, Garrod O, et al. Arterial thromboembolism in 250 cats in general practice: 2004–2012. J Vet Intern Med 2014; 28: 102–108.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15. Luis Fuentes V. Arterial thromboembolism: risks, realities, and a rational first-line approach. J Feline Med Surg 2012; 14: 459–470.

  • 16. Scansen BA, Vitt J, Chew DJ, et al. Comparison of forelimb and hindlimb systolic blood pressures and proteinuria in healthy Shetland Sheepdogs. J Vet Intern Med 2014; 28: 277–283.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17. Grimes DA, Schulz KF. Compared to what? Finding controls for case-control studies. Lancet 2005; 365: 1429–1433.

  • 18. van den Bosch MAAJ, van der Graaf Y, Eikelboom BC, et al. Distal aortic diameter and peripheral arterial occlusive disease. J Vasc Surg 2001; 34: 1085–1089.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19. Carter AJ, Van Heerden J. Aortic thrombosis in a dog with glomerulonephritis. J S Afr Vet Assoc 1994; 65: 189–192.

  • 20. Cook AK, Cowgill LD. Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985–1992). J Am Anim Hosp Assoc 1996; 32: 313–322.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21. Felix N, Mouro S, Velela CL, et al. Canine leishmaniasis with nephrotic syndrome and aortic and caudal vena caval thromboembolism. J Vet Emerg Crit Care 2008; 18: 526–531.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22. Littman MP. Protein-losing nephropathy in small animals. Vet Clin North Am Small Anim 2011; 41: 31–62.

  • 23. Nichols R. Complications and concurrent disease associated with canine hyperadrenocorticism. Vet Clin North Am Small Anim 1997; 27: 309–320.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24. Teshima T, Hara Y, Taoda T, et al. Cushing's disease complicated with thrombosis in a dog. J Vet Med Sci 2008; 70: 487–491.

  • 25. Erem C, Nuhoglu I, Yilmaz M, et al. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. J Endocrinol Invest 2009; 32: 169–174.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26. Hargis AM, Stephens LC, Benjamin SA, et al. Relationship of hypothyroidism to diabetes mellitus, renal amyloidosis, and thrombosis in purebred Beagles. Am J Vet Res 1981; 42: 1077–1081.

    • Search Google Scholar
    • Export Citation
  • 27. MacGregor JM, Rozanski EA, McCarthy RJ, et al. Cholesterol-based pericardial effusion and aortic thromboembolism in a 9-year-old mixed-breed dog with hypothyroidism. J Vet Intern Med 2004; 18: 354–358.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28. Erem C. Coagulation and fibrinolysis in thyroid dysfunction. Endocrine 2009; 36: 110–118.

  • 29. Chadarevian R, Bruckert E, Ankri A, et al. Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost 1998; 79: 99–103.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30. Guimarães AHC, de Bruijne ELE, Lisman T, et al. Hypofibrinolysis is a risk factor for arterial thrombosis at young age. Br J Haematol 2009; 145: 115–120.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31. Nadar SK, Tayebjee MH, Messerli F, et al. Target organ damage in hypertension: pathophysiology and implications for drug therapy. Curr Pharm Des 2006; 12: 1581–1592.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32. Wall U, Jern C, Bergbrant A, et al. Enhanced levels of tissue-type plasminogen activator in borderline hypertension. Hypertension 1995; 26: 796–800.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement